natgillin/translations-raw huggingface dataset:
● if you develop signs of a severe allergic reaction (such as difficulty in breathing, wheezing or hives) while on this medication, seek medical help immediately. 
• če med prejemanjem tega zdravila opazite znake hude alergijske reakcije (kot so težave z dihanjem, hropenje ali izpuščaj), takoj poiščite zdravniško pomoč,
Body weight kg (lbs) 
Telesna masa kg (lbs)
Transplantation 
Presaditve
The device is for single use only and is then to be discarded. 
Pripomoček je namenjen enkratni uporabi, potem pa ga je treba zavreči.
● if you are being treated with telbivudine, a medicine for hepatitis B infection (see “Other medicines and Pegasys”). 
• se zdravite s telbivudinom, zdravilom za okužbo z virusom hepatitisa B (glejte “Druga zdravila in zdravilo Pegasys”).
Pegasys treatment was associated with decreases in absolute CD4+ cell counts within the first 4 weeks without a reduction in CD4+ cell percentage. 
Zdravljenje z zdravilom Pegasys je bilo povezano z zmanjšanjem absolutnega števila celic CD4+ v prvih 4 tednih zdravljenja, odstotek celic CD4+ pa ni bil zmanjšan.
Because of the potential for adverse reactions in breastfed infants, breastfeeding should be discontinued prior to initiation of treatment. 
Zaradi možnih neželenih učinkov pri dojenih otrocih je treba pred začetkom zdravljenja dojenje prekiniti.
Physicians considering treatment in these patients should carefully weigh the risks versus the benefits of re-treatment. 
Ko zdravniki razmišljajo o zdravljenju teh bolnikov, naj skrbno pretehtajo tveganja in koristi ponovnega zdravljenja.
● Press the injection site with a small bandage or sterile gauze if necessary for several seconds. 
● Na mesto injiciranja pritisnite majhen ovoj ali sterilno gazo in jo, če je treba, držite nekaj sekund.
Do not touch the tip of the syringe. 
Ne dotikajte se vrha brizge.
The duration of combination treatment in children with chronic hepatitis C varies from 6 to 12 months depending on the type of virus your child is infected with and their response to therapy. 
Kombinirano zdravljenje pri otrocih s kroničnim hepatitisom C traja od 6 do 12 mesecev, odvisno od tipa virusa, s katerim je okužen vaš otrok, in njihovega odziva na zdravljenje.
In general, the safety profile observed in paediatric patients was similar to that seen in adults. 
Na splošno je bil varnostni profil pri pediatričnih bolnikih podoben varnostnemu profilu pri odraslih.
The decision to treat should be made on a case by case basis (see section 4.4). 
Odločitev za zdravljenje je potrebno sprejeti za vsak primer posebej (glejte poglavje 4.4).
● if you are infected with both the hepatitis C virus and the human immunodeficiency virus, and your liver does not work properly (e.g. your skin has become yellow). 
• če ste okuženi z virusom hepatitisa C in virusom humane imunske pomanjkljivosti, vaša jetra pa ne delujejo pravilno (npr. če je vaša koža postala rumena),
You can save the swab to clean the skin area where you will inject Pegasys. 
Krpico lahko shranite za čiščenje površine kože, kjer boste injicirali zdravilo Pegasys.
Reproductive toxicity studies have not been performed with Pegasys. 
Študije reproduktivne toksičnosti z zdravilom Pegasys niso izvajali.
If you are injecting this medicine yourself, you will be instructed how to give the injection. 
Če si boste zdravilo injicirali sami, vas bodo poučili o pravilnem postopku.
Let the skin dry for 10 seconds. 
Počakajte 10 sekund, da se koža osuši.
Take the pre-filled pen out of the refrigerator. 
Vzemite napolnjeni injekcijski peresnik iz hladilnika.
NPV Sensitivity Specificity HBeAg-positive(a) 
NPV Občutljivost Specifičnost HBeAg-pozitivni
The “Instructions for the User”, provided in the carton, must be followed carefully by the patient. 
Navodila za uporabnika, ki so dodana v škatli, mora bolnik skrbno upoštevati.
The frequency depends on the treatment duration and the dose of ribavirin (see section 4.8). 
Pogostnost je odvisna od trajanja zdravljenja in od odmerka ribavirina (glejte poglavje 4.8).
Push the plunger up slowly to the correct dose. 
Bat počasi potisnite do pravilnega odmerka.
4) Choose and prepare an injection site 5) Remove cap 
4) Izberite in pripravite mesto vboda 5) Odstranite pokrovček
What Pegasys is and what it is used for 
Kaj je zdravilo Pegasys in za kaj ga uporabljamo
Patients with advanced fibrosis were assigned to Pegasys treatment (group C, n=10). 
Bolnike z napredovalo fibrozo so določili za zdravljenje z zdravilom Pegasys (skupina C, n = 10).
● Do not repeat the injection 
• Ne ponavljajte injiciranja.
Body system Very common 
Organski sistem zelo pogosti pogosti
● if you develop any signs of bleeding or unusual bruising, check with your doctor immediately. 
• če opazite znake krvavitev ali nenavadne modrice, takoj obvestite svojega zdravnika,
Study NV15496 + NV15497 + NV15801 
Študija NV15496 + NV15497 + NV15801
If necessary, an inter-disciplinary approach including a mental health care provider or addiction specialist should be considered to evaluate, treat and follow the patient. 
Če je potrebno, je treba razmisliti o sodelovanju z drugimi specialisti kot so specialist za duševno zdravje ali specialist za zdravljenje odvisnosti, ter stanje oceniti, spremljati in bolnika zdraviti.
• Neonates and young children up to 3 years old, because of the excipient benzyl alcohol (see section 4.4 for benzyl alcohol) 
• novorojenčki in otroci do tretjega leta starosti, zaradi pomožne snovi benzilalkohola (glejte poglavje 4.4 za benzilalkohol),
● a short needle for the subcutaneous injection 
• kratka igla za podkožno injekcijo,
These patients had stable HIV disease and mean CD4 T-cell count was about 500 cells/µl. 
Ti bolniki so imeli stabilno bolezen HIV, srednje število celic CD4+ pa je bilo približno 500 celic/μl.
● remove the cap until you are ready to inject. 
• odstranite pokrovčka, dokler niste pripravljeni za injiciranje;
Do not use Pegasys if you are taking telbivudine (see “Do not use Pegasys”) because the combination of these medicines increases the risk of developing peripheral neuropathy (numbness, tingling, and/or burning sensations in the arms and/or legs). 
Če jemljete telbivudin, ne uporabljajte zdravila Pegasys (glejte “Ne uporabljajte zdravila Pegasys, če”), ker kombinacija teh zdravil poveča tveganje za nastanek periferne nevropatije (otopelost, mravljinci in/ali pekoč občutek v rokah, nogah ali obojih).
This would be particularly important in patients with a known history of zidovudine induced anaemia. 
To je še posebej pomembno pri bolnikih, pri katerih je znano, da je pri njih prišlo do anemije zaradi zidovudina.
Exacerbation of anaemia due to ribavirin has been reported when zidovudine is part of the regimen used to treat HIV although the exact mechanism remains to be elucidated. 
O poslabšanju anemije zaradi ribavirina so poročali, kadar je bil zidovudin del sheme zdravljenja HIV, čeprav natančen mehanizem ni znan.
Chronic Hepatitis B: Pegasys is usually used alone. 
Kronični hepatitis B: zdravilo Pegasys se običajno uporablja samostojno.
A total of 55 patients received initial combination treatment of Pegasys plus ribavirin, of whom 51% were female, 82% were Caucasian, and 82% were infected with HCV genotype 1. 
Skupno 55 bolnikov je prejelo začetno kombinacijo zdravljenja z zdravilom Pegasys in ribavirinom, od tega je bilo 51 % žensk, 82 % belcev in 82 % okuženih s HCV genotipa 1.
If your female partner is not pregnant now, but is of childbearing potential, she must be tested for pregnancy each month during treatment and for the 7 months after treatment has stopped. 
Če vaša partnerka ni noseča, vendar je v rodni dobi, mora vsak mesec v času zdravljenja in 7 mesecev po končanem zdravljenju opraviti test nosečnosti.
Odds Ratio (95% CI) 
Razmerje obetov (95-% CI)
Appropriate antiinfective therapy should be started immediately and discontinuation of therapy should be considered. 
Potrebno je takoj pričeti z ustreznim zdravljenjem proti okužbam in razmisliti o prekinitvi zdravljenja.
● if you have psoriasis, it may get worse during treatment with Pegasys. 
• če imate psoriazo, ki se lahko med zdravljenjem z zdravilom Pegasys poslabša,
If treatment with alfa interferon is judged necessary in these patients, the presence of psychiatric co-morbidities and the potential for other substance use should be carefully assessed and adequately managed before initiating therapy. 
Če je zdravljenje z interferoni alfa pri teh bolnikih nujno, je treba obstoječe simptome psihiatričnih motenj in možnost jemanja drugih substanc pazljivo oceniti in ustrezno obravnavati pred pričetkom zdravljenja.
In case of persistent or unexplained pulmonary infiltrates or pulmonary function impairment, treatment should be discontinued. 
Pri dolgotrajnih ali nerazložljivih pljučnih infiltratih ali motenem pljučnem delovanju moramo zdravljenje prekiniti.
To calculate BSA, it is recommended to use Mosteller's equation: 
Za izračun telesne površine je priporočljiva uporaba Mostellerjeve formule:
Your other hand will be free to move the plunger of the syringe. 
Svojo drugo prosto roko uporabite za premikanje bata brizge.
Study NV15495 specifically recruited patients with a histological diagnosis of cirrhosis (about 80%) or transition to cirrhosis (about 20%). 
Študija NV15495 je specifično vključevala bolnike s histološko diagnozo ciroze (okoli 80 %) ali prehoda v cirozo (okoli 20 %).
More frequent monitoring of hepatic function was recommended in all instances. 
Pri vseh primerih so priporočali pogostejše spremljanje jetrne funkcije.
What Pegasys is and what it is used for What you need to know before you use Pegasys How to use Pegasys 
Kaj je zdravilo Pegasys in za kaj ga uporabljamo Kaj morate vedeti, preden boste uporabili zdravilo Pegasys Kako uporabljati zdravilo Pegasys
May cause toxic reactions and allergic reactions in infants and children up to 3 years old. 
Lahko povzroči toksične in alergijske reakcije pri dojenčkih in otrocih do 3. leta starosti.
Patients in groups A and C (n=111) were treated with Pegasys once weekly for 48 weeks according to BSA categories, whereas patients in group B were observed for a period of 48 weeks (principal observation period). 
Bolnike iz skupin A in C (n = 111) so zdravili z zdravilom Pegasys enkrat na teden 48 tednov glede na telesno površino, razdeljeno v kategorije, bolnike iz skupine B pa so opazovali 48 tednov (glavno obdobje opazovanja).
Keep the protective cap on the pre-filled pen until Step 5. 
Pustite zaščitni pokrovček na napolnjenem injekcijskem peresniku do koraka 5.
Be sure not to touch the cleaned area prior to injection. 
Ne dotikajte se očiščenega mesta, preden si date injekcijo.
p value 
p-vrednost
In some cases, dose modification may be necessary (see section 4.2). 
V nekaterih primerih je treba odmerek prilagoditi (glejte poglavje 4.2).
< 250 cells/mm3 (or febrile neutropenia): discontinue treatment. 
< 250 celic/mm3 (ali febrilna nevtropenija): ukinitev zdravljenja.
24 weeks or 48 weeks 
24 ali 48 tednov
● any part of the pre-filled pen appears to be damaged 
• kateri koli del napolnjenega injekcijskega peresnika izgleda poškodovan;
Positive 
Pozitiven
The expected benefit of treatment should be carefully weighed against the safety findings observed for children and adolescents in the clinical trials on a case by case basis (see sections 4.8 and 5.1). 
Pričakovano korist zdravljenja je treba pri vsakem primeru posebej skrbno pretehtati glede na znane izsledke kliničnih preskušanj o varnosti pri otrocih in mladostnikih (glejte poglavji 4.8 in 5.1).
< 10 g/dl, and ≥ 8.5 g/dl 
< 10 g/dl in ≥ 8,5 g/dl
Tell your doctor if you are taking medicines for asthma, because the dose for your asthma medicine may need to be changed. 
Če jemljete zdravila proti astmi, to povejte svojemu zdravniku, ker bo zdravnik morda moral prilagoditi odmerek zdravila proti astmi.
Exposure to didanosine or its active metabolite (dideoxyadenosine 5'-triphosphate) is increased in vitro when didanosine is coadministered with ribavirin. 
Izpostavljenost didanozinu ali njegovemu aktivnemu presnovku (dideoksiadenozin 5`- trifosfat) je povečana in vitro, če didanozin jemljemo sočasno z ribavirinom.
● Hold the vial and syringe in one hand and turn the vial and the syringe upside down (4). 
● Vialo in brizgo primite v eno roko in ju obrnite navzgor (4).
You should inject your regularly scheduled dose immediately on Friday and take your next injection on Wednesday (5 days after your Friday dose). 
V petek si takoj injicirajte priporočeni odmerek, naslednji odmerek pa si injicirajte v sredo (5 dni po petkovem odmerku).
No dose adjustment is required for adult patients with mild or moderate renal impairment. 
Prilagoditev odmerka pri odraslih bolnikih z blago ali zmerno ledvično okvaro ni potrebna.
Dose adjustment for adverse reactions in adult patients 
Prilagajanje odmerkov zaradi neželenih učinkov pri odraslih bolnikih
● Do not touch the tip of the pre-filled pen, since needlestick injuries may occur. 
• Ne dotikajte se konice napolnjenega injekcijskega peresnika, ker lahko pride do poškodb (vboda z iglo).
Adjustments in the recommended dosage of 180 micrograms once weekly are not necessary when instituting Pegasys therapy in elderly patients (see section 5.2). 
Prilagoditve priporočenega odmerka 180 mikrogramov enkrat na teden pri uvajanju zdravljenja z zdravilom Pegasys pri starejših bolnikih niso potrebne (glejte poglavje 5.2).
The pharmacokinetics of Pegasys after single subcutaneous injections was comparable between male and female healthy subjects. 
Farmakokinetika zdravila Pegasys je bila po enkratni podkožni injekciji med zdravimi moškimi in ženskami primerljiva.
The side effect may develop at various time points during treatment, typically several months after starting treatment with Pegasys. 
Neželeni učinek se lahko pojavi ob različnih časovnih točkah zdravljenja, običajno nekaj mesecev po začetku zdravljenja z zdravilom Pegasys.
Do not exceed the recommended dose. 
Priporočenega odmerka ne smete prekoračiti.
Unless otherwise noted, the management of all other toxicities should follow the adult recommendations. 
Pri obravnavi vseh ostalih toksičnostih je treba slediti priporočilom za odrasle, razen če ni navedeno drugače.
● Check for air bubbles in the syringe. 
● Preverite, če so v brizgi zračni mehurčki.
● if you have a problem with your liver other than hepatitis B or C. 
• če imate težave z jetri in vzrok ni hepatitis B ali C,
Patients should be closely monitored during therapy and even after treatment discontinuation. 
Bolnike je treba skrbno spremljati med zdravljenjem in tudi po njegovem zaključku.
16 weeks(a) or 24 weeks 
16 tednov(a) ali
Use Pegasys exactly as described by your doctor, for as long as prescribed by your doctor. 
Zdravilo Pegasys uporabljajte natančno po zdravnikovih navodilih in tako dolgo, kot vam je predpisal zdravnik.
If it is not used within 5 minutes, the pre-filled pen should be disposed and a new pre-filled pen should be used. 
Če ga ne uporabite v 5 minutah, je treba napolnjeni injekcijski peresnik zavreči in uporabiti novega.
Pegasys treatment may be initiated or continued if TSH levels can be maintained in the normal range by pharmaceutical means. 
Zdravljenje z zdravilom Pegasys lahko začnemo ali nadaljujemo, če lahko z zdravilom vzdržujemo koncentracije TSH v normalnih mejah.
● if you have thyroid disease that is not well controlled with medicines. 
• če imate bolezen ščitnice, ki ni popolnoma nadzorovana z zdravili,
Needle-shield (only visible once cap is removed in Step 5) 
Ščitnik za iglo (viden samo, ko je pokrovček odstranjen v koraku 5)
SI unit = µmol/l) 
SI-enote (µmol/l)
Excipient with known effect: Benzyl alcohol (10 mg/ 1 ml) For the full list of excipients, see section 6.1. 
Pomožna snovi z znanim učinkom: benzilalkohol (10 mg/1 ml) Za celoten seznam pomožnih snovi glejte poglavje 6.1.
While holding pre-filled pen firmly in place, press the activation button with your thumb and immediately release the button. 
Ko trdno držite napolnjeni injekcijski peresnik, s palcem pritisnite sprožilni gumb in ga nemudoma spustite.
● Select the injection site in the abdomen or thigh (except your navel or waistline). 
● Izberite mesto injiciranja na trebuhu ali stegnu (razen področje popka in pasu).
A total of 283/1351 (21%) of patients had advanced fibrosis or cirrhosis, 85/1351 (6%) had cirrhosis. 
Skupno 283 od 1351 bolnikov (21 %) je imelo napredovalo fibrozo ali cirozo, 85 od 1351 bolnikov (6 %) pa je imelo cirozo.
● if you develop symptoms associated with depression (e.g. feelings of sadness, dejection, etc.) (see section 4). 
• če se pojavijo simptomi, povezani z depresijo (kot npr. občutek žalosti, potrtosti itd.) (glejte poglavje 4),
Peginterferon alfa-2a serum concentrations are sustained throughout one full week (168 hours). 
Koncentracije peginterferona alfa-2a v serumu so bile nespremenjene en teden (168 ur).
Monotherapy for hepatitis C should only be considered in case of contraindication to other medicinal products. 
Samostojno zdravljenje hepatitisa C uvedemo le v primerih kontraindikacij drugih zdravil.
The mean exposure (AUC) during the dosing interval is predicted to be 25% to 70% higher than that observed in adults receiving 180 mcg fixed dosing. 
Predvideva se, da naj bi bila povprečna izpostavljenost (AUC) med intervali odmerjanja od 25 % do 70 % višja od tiste, ki so jo opazili pri odraslih, ki so prejemali stalen odmerek 180 µg.
The recommended total duration of therapy is 48 weeks. 
Priporočeno skupno trajanje zdravljenja je 48 tednov.
Table 3: Dose adjustment for adverse reactions in adult patients (for further guidance see also text above) 
Preglednica 3: Prilagajanje odmerkov zaradi neželenih učinkov pri odraslih bolnikih (za nadaljnja navodila glejte tudi zgornje besedilo).
A puncture-proof container with lid for safe disposal of used pens 
Zabojnik za ostre predmete s pokrovom za varno odstranjevanje rabljenih injekcijskih peresnikov
If this reaction occurs, they should be advised to rinse out their mouth thoroughly afterwards. 
Če se pojavi bruhanje, je treba bolnikom svetovati, naj si takoj zatem temeljito izperejo usta.
Ribavirin therapy is contraindicated in women who are pregnant. 
Zdravljenje z ribavirinom je pri nosečnicah kontraindicirano.
● Insert the needle all the way into the pinched skin at an angle of 45° to 90° (6). 
● Iglo pod kotom 45° do 90° do konca potisnite v kožno gubo (6).
Paediatric patients 5 years of age and older 
Pediatrični bolniki, stari 5 let in več
Paediatric patients 3 years of age and older 
Pediatrični bolniki, stari 3 leta in več
NPV= negative predictive value; Sensitivity = % of all responders not meeting the stopping rule; Specificity = % of all non-responders meeting stopping rule (a) 
NPV = negativna napovedna vrednost; občutljivost = % vseh odzivnih bolnikov, ki ne izpolnjujejo merila za prekinitev zdravljenja; specifičnost = % vseh neodzivnih bolnikov, ki izpolnjujejo merilo za prekinitev zdravljenja.
Transient rashes do not necessitate interruption of treatment. 
Pri pojavu prehodnega izpuščaja prekinitev zdravljenja ni potrebna.
1-5% of patients treated with Pegasys developed neutralising anti-interferon antibodies. 
Pri 1 do 5 % bolnikov, ki so se zdravili z zdravilom Pegasys, so se pojavila nevtralizirajoča protitelesa proti interferonu.
5) Remove cap 
5) Odstranite pokrovček
Prior to initiation of Pegasys therapy, TSH and T4 levels should be evaluated. 
Pred začetkom zdravljenja z zdravilom Pegasys moramo določiti koncentracije TSH in T4.
No single biomarker with a cut-off can be identified to optimize all the operating characteristics (negative predictive value [NPV], sensitivity, specificity) and practical characteristics (simplicity, convenience). 
Posamezen biološki označevalec z znano pražno vrednostjo ter optimalnimi značilnostmi (negativna napovedna vrednost (NPV - negative predicitve value)), občutljivost, specifičnost) in praktično uporabnostjo (preprostost, prikladnost), ni poznan.
● if you are an adult who has or had a history of substance abuse (e.g. alcohol or drugs) 
• če ste odrasli in imate ali ste imeli v anamnezi zlorabo psihoaktivnih substanc (alkohol ali droge),
Some people get depressed when taking Pegasys alone or in combination treatment with ribavirin, and in some cases people have had suicidal thoughts or aggressive behaviour (sometimes directed against others such as thoughts about threatening the life of the others). 
Nekateri bolniki so po jemanju zdravila Pegasys, samega ali v kombinaciji z ribavirinom, postali depresivni, v nekaterih primerih pa so imeli samomorilske misli ali so se vedli agresivno (včasih proti drugim osebam, npr. razmišljanje o umoru).
 The pre-filled pen is now unlocked and ready for injection. 
 Napolnjeni injekcijski peresnik je tako odklenjen in pripravljen za injiciranje.
In some cases, dose reduction to 90 micrograms or 45 micrograms is necessary. 
V nekaterih primerih moramo odmerek zmanjšati na 90 mikrogramov ali
● Wait for the area to dry. 
● Počakajte, da se koža posuši.
Study WV16240 recruited patients who were positive for HBeAg, while study WV16241 recruited patients who were negative for HBeAg and positive for anti-HBe. 
V študijo WV16240 so bili vključeni bolniki, ki so bili HBeAg pozitivni, v študijo WV16241 pa so bili vključeni HBeAg negativni in anti-HBe pozitivni bolniki.
Anti-interferon antibodies 
Protitelesa proti interferonu
Therefore, the combination of Pegasys with telbivudine is contraindicated (see section 4.3). 
Kombinacija zdravila Pegasys in telbivudina je zato kontraindicirana (glejte poglavje 4.3).
For persistent or increasing elevations ≥5 but <10 x ULN, reduce dose with a 1 level adjustment and monitor weekly ALT level to ensure it is stable or decreasing. 
Pri dolgotrajno zvišanih vrednostih ali zviševanju vrednosti ≥ 5, vendar < 10-krat ULN - zmanjšanje odmerka 1. stopnje in tedensko spremljanje vrednosti ALT, da se prepričamo, ali so vrednosti stabilne oziroma se zmanjšujejo.
Dental and periodontal disorders 
Zobne in periodontalne bolezni
If VKH syndrome is suspected, antiviral treatment should be withdrawn and corticosteroid therapy discussed (see section 4.8). 
Če sumimo na VKH sindrom, je treba protivirusno zdravljenje prekiniti in razmisliti o zdravljenju s kortikosteroidi (glejte poglavje 4.8).
Undesirable effects reported in clinical studies are grouped according to frequency as follows: very common (≥ 1/10), common 
Neželeni učinki, o katerih so poročali v kliničnih preskušanjih, so navedeni po pogostnosti na naslednji način: zelo pogosti (≥ 1/10), pogosti (≥ 1/100 do
Most laboratory abnormalities noted during the clinical trial returned to baseline levels shortly after discontinuation of treatment. 
Večina laboratorijskih nepravilnosti, ki so jih opazili med kliničnim preskušanjem se je kmalu po prekinitvi zdravljenja vrnila na izhodiščne vrednosti.
For adults, dose reduction is recommended if the absolute neutrophil count (ANC) is 500 to < 750 cells/mm3. 
Pri odraslih je zmanjšanje odmerka priporočljivo, če je absolutno število nevtrofilcev (ANC - Absolute Neutrophil Count) 500 do < 750 celic/mm3.
Do not warm up pre-filled pen in any other way. 
Napolnjenega injekcijskega peresnika ne segrevajte na kakršen koli drug način.
7) Give injection 
7) Dajte injekcijo
In combination therapy with ribavirin, take notice of the respective informing texts of ribavirin containing medicinal products. 
Pri kombiniranem zdravljenju z ribavirinom bodite pozorni na ustrezno besedilo v informacijah o zdravilih, ki vsebujejo ribavirin.
Make sure you have taken your thumb off the activation button. 
Odstranite palec s sprožilnega gumba.
values return to > 1000 cells/mm3. 
ne vrnejo na > 1000 celic/mm3.
From mass balance, tissue distribution and whole body autoradioluminography studies performed in rats, peginterferon alfa-2a is distributed to the liver, kidney and bone marrow in addition to being highly concentrated in the blood. 
Raziskave masnega ravnovesja, porazdelitve po tkivih in raziskave avtoradioluminografije celega telesa pri podganah so pokazale, da se peginterferon alfa-2a porazdeljuje v jetra, ledvice in kostni mozeg poleg tega, da je visoko koncentriran v krvi.
Store the container out of reach of children at all times. 
Zabojnik za ostre predmete ves čas shranjujte izven dosega otrok.